# Nuclide record fdg-pet-response-adapted-therapy (pairing). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/pairings/fdg-pet-response-adapted-therapy/>
  a schema:MedicalTherapy ;
  nuclide:kind "pairing" ;
  schema:identifier "fdg-pet-response-adapted-therapy" ;
  schema:name "FDG PET then response-adapted chemotherapy"@en ;
  schema:description "In Hodgkin lymphoma, a PET scan taken partway through chemotherapy is used to decide whether to keep the same treatment, drop a harsh drug, or step up to something stronger. Trials show this scan-guided approach keeps most patients well without adding one particular lung-damaging drug."@en ;
  schema:url <https://nuclide.cc/pairings/fdg-pet-response-adapted-therapy/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://thd.org.tr/thdData/userfiles/file/RATHL_Adapted_Treatment_Guided_by_Interim_PET-CT_Scan-2016_NEJM.pdf>, <https://pmc.ncbi.nlm.nih.gov/articles/PMC7268111/>, <https://ascopubs.org/doi/10.1200/JCO.23.01177> ;
  nuclide:tag "Hodgkin lymphoma", "response-adapted therapy", "FDG PET" ;
  nuclide:related <https://nuclide.cc/trials/rathl/>, <https://nuclide.cc/key-papers/paper-rathl-interim-pet-adapted-abvd-advanced-hodgkin-nejm-2016/>, <https://nuclide.cc/technologies/quantitative-imaging-biomarkers/>, <https://nuclide.cc/people/pierre-vera/> ;
  nuclide:pairs <https://nuclide.cc/technologies/fdg-pet/>, <https://nuclide.cc/technologies/pet-adapted-therapy/> .